NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
11/24/2025
Back to search
Official data from USPTO
MEDICXI
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
MEDICXI
ST13
US500000087766573Class
35, 36, 41
Filing
87766573
Registration
5962119
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
43
Latest update
11/25/2025
Trademark type
Word
Nice classes
35, 36, 41
Filing date
01/23/2018
Registration date
01/14/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/24/2025
Last transaction
11/25/2025
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
Filing basis
Foreign priority
First use anywhere
2017-01-00
First use in commerce
2017-01-00
Drawing code
4
Owner type
99
Owner location
St Helier
Examiner
SHANAHAN, PATRICK
Current location
Historical data usage
Holders and representatives
Holders
Medicxi Ventures Management (Jersey) Limited
Representatives
Brian R. McGinley Dentons US LLP
Technical classification
Nice Classes
Class 35Class 36Class 41
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Business appraisals; Business management; Business management analysis; Business planning; Business consultation
Class 36
Financial consultation; Financial analyses; Financial planning; Financial risk management; Financial asset management; Financial consultancy and advisory services; Venture capital financing; Venture capital funding services to emerging and start-up companies; Venture capital funding services for companies; Venture capital advisory services; Venture capital fund management; Fundraisingfor the purpose of investing in life sciences companies; Equity capital investment; Capital investment; Capital investment consulting
Class 41
Arranging and conducting educational conferences and seminars in the field of life sciences and finance; Conducting workshops for training in the field of life sciences and finance especially in drug and medicines development; Educational servicesconducting conferences in field of life sciences and finance
Publications
History of USPTO decisions and trademark events.
43 publications found
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
11/24/2025
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
11/24/2025
PR23
POST REGISTRATION ACTION MAILED - SEC. 8 & 15
08/20/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/08/2025
E815
TEAS SECTION 8 & 15 RECEIVED
04/07/2025
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
01/14/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
01/14/2020
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
12/12/2019
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
12/11/2019
SUPC
STATEMENT OF USE PROCESSING COMPLETE
11/19/2019
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
11/19/2019
IUAF
USE AMENDMENT FILED
11/08/2019
EISU
TEAS STATEMENT OF USE RECEIVED
11/08/2019
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/08/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/08/2019
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
05/28/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/02/2019
PUBO
PUBLISHED FOR OPPOSITION
04/02/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/13/2019
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
02/28/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/25/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/23/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/22/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/22/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
01/30/2019
GNRT
NON-FINAL ACTION E-MAILED
01/30/2019
CNRT
NON-FINAL ACTION WRITTEN
01/30/2019
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
01/25/2019
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
12/24/2018
FIXD
ELECTRONIC RECORD REVIEW COMPLETE
12/11/2018
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
11/30/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/28/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/28/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/28/2018
ALIE
ASSIGNED TO LIE
11/20/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/09/2018
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
05/10/2018
GNRT
NON-FINAL ACTION E-MAILED
05/10/2018
CNRT
NON-FINAL ACTION WRITTEN
05/10/2018
DOCK
ASSIGNED TO EXAMINER
05/03/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/03/2018
NWAP
NEW APPLICATION ENTERED
01/26/2018
Continuous trademark protection
Get notified about every new filing that threatens MEDICXI or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.